Abstract
Hemorrhagic bullous dermatosis is a rare, generalized skin reaction with unknown pathogenesis, described in association with heparin therapy. Heparin is known to cause injection site reactions and ecchymosis but rarely causes global cutaneous reactions, making hemorrhagic bullous dermatosis an unusual clinical entity. The condition occurs within 5 to 21 days of the initiation of therapy at locations distant to the site of subcutaneous heparin injection. Characteristic lesions are painless, hemorrhagic papules on a background of uninvolved skin. The histologic findings are usually nonspecific but can help rule out thrombosis, vasculitis, or marked inflammatory changes. Skin lesions usually resolve after discontinuation of heparin. We present a case of hemorrhagic bullous dermatosis in an 82-year-old woman recently started on warfarin therapy and briefly review skin effects of anticoagulation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
